CCLD Stock Analysis: Buy, Sell, or Hold?
CCLD - CareCloud, Inc. Common Stock
$2.65
0.21 (8.61%)
▲
5d:
+18.83%
30d:
+19.37%
90d:
-11.37%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Get Alerted When CCLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CCLD is 10.4% above its trading range ($2.40). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CCLD is 10.4% above its trading range ($2.40). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.10
Based on -8.0% avg growth
INTRINSIC VALUE TODAY
$1.30
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCLD is currently trading at $2.65, which is considered extended relative to its 30-day fair value range of $2.16 to $2.40. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.0) compared to its historical average (11.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.6% over the next few years. This pessimistic expectation contrasts with the company's recent 5739.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CCLD is in a strong downtrend. The price is approaching resistance at $2.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.6% recently.
Market Sentiment: CCLD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+131.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CCLD is in a strong downtrend. The price is approaching resistance at $2.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.6% recently.
Market Sentiment: CCLD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+131.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.16 -
$2.40
Company Quality Score
58/100
(HOLD)
Options IV Signal
66th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
All Signals
- BEARISH: Price significantly overextended (+10.4% above its trading range)
- NEUTRAL: Options fairly priced (IV 66th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.6%)
- BULLISH: Trading 131.1% below Wall St target ($6.12)
Trading Range Analysis
30-Day Trading Range
$2.16 -
$2.40
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.36
(13.5%)
Support & Resistance Levels
Support Level
$2.15
Resistance Level
$2.69
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.04
Wall Street Target
$6.13
(+131.1%)
Revenue Growth (YoY)
13.2%
Earnings Growth (YoY)
5739.0%
Profit Margin
7.9%
Valuation Discount vs History
-6.6% cheaper
PE vs Historical
9.0 vs 11.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.6%
(market-implied from PE analysis)
1-Year Target
$2.48
(-7%)
2-Year Target
$2.31
(-13%)
3-Year Target
$2.16
(-19%)
3-Yr Target (if PE normalizes)
(PE: 9→11)
$2.65
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: -20.0%)
$4.43
(+67%)
Base:
(SPY PE: 9.0, Growth: -20.0%)
$1.93
(-27%)
Bear:
(PE: 7.7, Growth: -20.0%)
$1.64
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 18.77 | Current EPS (TTM): $0.13
Bull Case
$5.37
(+103%)
Analyst growth 100.0%, PE expands to 20.7
Base Case
$4.88
(+84%)
Market implied 100.0%, PE stable at 18.8
Bear Case
$1.66
(-37%)
Severe decline -20.0%, PE contracts to 16.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.0 to 11.1
Stabilization Target:
$3.26
(+22.9%)
PE Expansion Potential:
+22.9%
Share & Embed Analysis
Last updated: August 04, 2026 12:49 AM ET
Data refreshes hourly during market hours. Next update: 1:49 AM
Data refreshes hourly during market hours. Next update: 1:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |
